Injector device for placing a subcutaneous infusion set

ABSTRACT

An injector device for transcutaneously placing at least a portion of a cannula of a medical device through the skin of a patient is provided. The injector device includes a device housing having a bore formed therein and a plunger slidably received within the bore. The plunger includes an insertion needle secured thereto for receiving the cannula of the medical device. The insertion needle remains secured to the plunger subsequent to placement of the medical device and the insertion needle and the injector are removable from the cannula while maintaining the transcutaneous placement of the cannula.

This application is a continuation of application Ser. No. 10/687,568,filed on Oct. 15, 2003, pending, which is a continuation-in-part ofPCT/DK02/00640, filed Sep. 27, 2002, which is a continuation-in-part ofapplication Ser. No. 09/995,237, filed Nov. 26, 2001, now U.S. Pat. No.6,830,562, which is a continuation-in-part of application Ser. No.09/967,400, filed Sep. 27, 2001, abandoned, and a continuation of DanishPatent Application No. PA 2001 01411 filed on Sep. 27, 2001, theentirety of these references are incorporated herein.

BACKGROUND OF THE INVENTION

This invention relates generally to an improved injector device for theplacement of a subcutaneous infusion set on a patient. Examples ofinjector devices for the placement of a subcutaneous infusion set aredisclosed in U.S. Pat. No. 6,093,172, U.S. Pat. No. 5,851,197 and WO99/33504, incorporated by reference herein.

Medical needles are widely used in the course of patient treatment,particularly for delivery of selected medications. In one form, hollowhypodermic needles are employed for transcutaneous delivery of themedication from a syringe or the like, see U.S. Pat. No. 5,665,071. Inanother, as shown in U.S. Pat. No. 5,591,188 incorporated herein byreference, an insertion needle used in conjunction with an injectordevice is employed for transcutaneous placement of a soft and relativelyflexible tubular cannula, followed by removal of the insertion needleand subsequent infusion of medical fluid to the patient through thecannula. U.S. Pat. No. 5,681,323 relates to an insertion device for anemergency cricothyrotomy tube.

It is often necessary for a patient to transcutaneously place themedical needle himself. For example, diabetic patients frequently placea subcutaneous infusion set with a cannula for subsequent programmabledelivery of insulin by means of a medication infusion pump. Suchsubcutaneous infusion sets are disclosed, for example, in U.S. Pat. No.4,755,173, U.S. Pat. No. 5,176,662, U.S. Pat. No. 5,257,980 and WO98/58693 which are incorporated by reference herein.

Some patients are reluctant or hesitant to pierce their own skin with amedical needle, and thus encounter difficulties in correct needleplacement for proper administration of the medication. Such difficultiescan be attributable to insufficient manual skill to achieve properneedle placement or alternately to anxiety associated with anticipateddiscomfort as the needle pierces the skin. This problem can beespecially significant with medications delivered via a subcutaneousinfusion set, since incorrect placement can cause kinking of the cannulaand resultant obstruction of medication flow to the patient. Cannulakinking can be due to infusion set placement at an incorrect anglerelative to the patient's skin, and/or needle placement with anincorrect force and speed of insertion.

The present invention is aimed at providing an improved injector device,which may allow for a shortening of the total time required for theplacement of an infusion set. The present invention also aims atproviding an improved spring-type drive for urging a plunger within ahousing to an advanced position.

SUMMARY OF THE INVENTION

In accordance with the invention, an injector device has a plunger witha medical needle which may be hollow to allow for discharge ofmedication when priming the infusion set, and which is adapted for thequick and easy transcutaneous placement through the skin of a patient ofthe cannula of a subcutaneous infusion set, the insertion needleextending through the infusion set and protruding from the end of thecannula. The injector device is designed to place the cannula with theinsertion needle extending therethrough, preferably with a controlledforce and speed of insertion, to ensure proper needle placement withminimal patient discomfort. The injector device may also allow placementof the insertion needle through the skin at a selected insertion angle.After priming and placement of the infusion set the injector device isremoved and delivery of medication is initiated.

Preferably, the injector device is provided to the patient as a sterilesealed, single use assembly including a subcutaneous infusion set with ahousing already mounted on the insertion needle of the injector device,thereby reducing the number of components to be handled by the patientprior to the placement of the subcutaneous infusion set. The injectordevice assembly may be designed such that no further packaging isrequired leading to substantial cost reductions.

More particularly, the injector device comprises a device housing,preferably having an elongated bore, and a plunger slidably receivedtherein for movement between an advanced position and a retractedposition, the plunger having substantially non-detachably securedthereto an insertion needle adapted to receive and support said cannulain a position with the cannula oriented for transcutaneous placementupon movement of the plunger with said needle from the retractedposition to the advanced position. A drive urges the plunger with acontrolled force and speed from the retracted position toward theadvanced position to transcutaneously place said cannula of saidsubcutaneous infusion set received on said insertion needle. Theinsertion needle on the plunger is removable from said cannula whilemaintaining the transcutaneous placement of the cannula. By is“substantially non-detachably” as used in the present application ismeant a connection, which will remain stable under normal conditions ofuse to allow the needle to remain on the plunger when retracting theinjector device from a patient's skin.

Preferably, the injector comprises a spring-loaded plunger having a headfor receiving the infusion set in a position with the insertion needleprojecting outwardly for transcutaneous placement through the skin of apatient. A front end of the housing is designed for being pressedagainst the skin of a patient, at a selected needle insertion site, andin an orientation with the needle disposed at a correct or desiredinsertion angle. A trigger member is operable to release the plunger andthereby permit the drive spring to carry the infusion set toward thepatient's skin with a controlled force and speed, resulting in propertranscutaneous placement of the insertion needle with minimal patientdiscomfort.

The invention also relates to a novel spring-type drive for urging theplunger of an injector device to the advanced position, preferably fortranscutaneously placing a subcutaneous infusion set, wherein the drivecomprises a number of individual, elongated flexible plastics members,preferably extending around a respective part of the periphery of theplunger, in the annular space between the plunger and a device housing.Each member is connected with the plunger and with the device housing.In the advanced position of the plunger, the plastics members areessentially plane and non-deformed. However, when moving the plunger tothe retracted position, the plastics members are bend, setting up therequired force that seeks to drive the plunger to an advanced position.The novel spring-type drive may also be implemented in injector devicesof the type disclosed in U.S. Pat. No. 6,093,172, U.S. Pat. No.5,851,197 and WO 99/33504 where the plunger head does not have aninsertion needle mounted thereon for receiving an infusion set, butincludes a recess adapted for receiving as well as supporting asubcutaneous infusion set.

BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings illustrate the invention.

FIG. 1 is a perspective schematic vertical cross-sectional viewillustrating an injector device embodying the novel features of theinvention,

FIG. 2 is a schematic cross-sectional view of the injector device shownin FIG. 1, with the end cap removed,

FIG. 3 is a schematic cross-sectional view of the injector device ofFIG. 1, with the plunger in the advanced position and after placement ofthe subcutaneous infusion set,

FIG. 4 is a view similar to FIG. 4 with end cap placed for protection ofthe protruding insertion needle,

FIG. 5 is an exploded perspective view illustrating the plunger andhousing parts of the injector device,

FIG. 6 is a highly schematic vertical partly cross-sectional viewillustrating an injector device according to a second embodiment of theinvention, prior to use,

FIG. 7 is a view similar to FIG. 6, illustrating the injector devicebeing made ready for use,

FIG. 8 is a view similar to FIG. 6 of the infusion set being primed,

FIG. 9 is a view similar to FIG. 6 with the plunger being retracted andthe injector device made ready for transcutaneous placement of theinfusion set,

FIG. 10 is a view similar to FIG. 6, with the infusion set being placedon a patient,

FIG. 11 is a view similar to FIG. 6, with the injection device beingremoved from the infusion set placed on the patient,

FIG. 12 is a horizontal perspective, cross-sectional view of the deviceshown in FIGS. 6-11, showing the spring-type drive with the plunger inthe advanced position, as seen along line 12-12 in FIG. 8,

FIG. 13 is a perspective view illustrating an injector device accordingto a third embodiment of the invention, prior to use,

FIG. 14 is a perspective, partly cross-sectional view of the device ofFIG. 13,

FIG. 15 is a view similar to FIG. 14, showing the plunger in theadvanced position,

FIG. 16 is a exploded perspective view illustrating the various parts ofthe injector device of FIGS. 13-15,

FIG. 17 is a perspective view of an infusion set suitable for use withthe injector device of the invention,

FIG. 18 is a cross-sectional view showing how priming of an infusion setmay be carried out using a hollow insertion needle,

FIG. 19 shows in an exploded view a presently preferred embodiment ofthe injector device assembly, similar to the embodiment of FIGS. 6-12,wherein the plunger has an insertion needle secured thereto.

FIGS. 20 a and 20 b show in a perspective view the injector device ofFIG. 19 with the plunger in the advanced position

FIGS. 21 a and 21 b show in a perspective view the injector device ofFIG. 19 with the plunger in the retracted position,

FIGS. 21 a-e are views similar to FIGS. 20 a, 21 a and 21 b with part ofthe housing being cut away,

FIG. 22 a and 22 b show an injector device without an insertion needlesecured to the plunger,

FIGS. 23 a and 23 b show a schematic cross-sectional view through theinfusion set of FIG. 17, without and with an insertion needle,respectively, and

FIG. 24 shows the injector device of FIG. 19 with a glucose sensor.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

An injector device shown schematically in FIG. 1 by the referencenumeral 10 is provided for quick and easy placement of a subcutaneousinfusion set 14, and may then be discarded safely. The infusion set 14with a cannula 26 extending therefrom is shown schematically only.

The injector device 10 includes a plunger 30 having thereon a medicalinsertion needle 12 with a pointed end 12A. The plunger 30 is arrangedfor longitudinal sliding movement within a device housing 28 between aforward advanced position (FIGS. 3 and 4) and a rearward retractedposition (FIGS. 1 and 2). The device housing 28 may have a circular,square or any desired cross-sectional shape. The device housing 28 andthe plunger 30 are preferably formed of a plastics material in amoulding process.

The infusion set 14 is used to infuse medical fluids such as insulin toa patient, and generally includes a housing with an internal chamber(not shown) that receives medication via infusion tubing. An enlargedbase 24 of the infusion set 14 is provided on the housing for stableaffixation thereof to the skin of the patient. The enlarged base 24 maycarry an adhesive and be provided with a release sheet 14′ which isremoved to expose the adhesive prior to placement of the infusion set.Alternatively, the base 24 may be sized to allow the infusion set to befixed to the patient by an adhesive patch. The infusion set has aprotruding soft and flexible cannula 26, which communicates with theinternal chamber, and a passage sealed by a sealing membrane extendsthrough the housing opposite the cannula 26. The medical insertionneedle 12 of the injector device 10 extends through the passage, intothe internal chamber and through the cannula 26, when the infusion set14 is mounted in position on the injector device. After transcutaneousplacement of the cannula 26, the injector device 10 with the insertionneedle 12 is retracted from the infusion set 14 to permit medicationdelivery through the cannula 26 to the patient.

Examples of subcutaneous infusion sets suitable for use with theinjector device of the present invention, and in particular inconjunction with the insertion needle of the injector device, are shownand described in U.S. Pat. Nos. 4,755,173, 5,176,662 and 5,257,980,European patent no. 956 879 and in international patent application no.98/58693, which are incorporated by reference herein. Such in fusionsets generally include a hollow cannula part. The insertion needle shownin those publications may be obviated through the present invention.Alternatively, the injector device according to the invention may beused to transcutaneously place a cannula associated with other types ofinfusion sets.

The invention provides a ready to use injector device, which may bemolded from a suitable plastics material. An injector device assemblyincluding the injector device and a subcutaneous infusion set willeffectively simplify the placement of an infusion set as the assembly,as delivered from the factory, provides an infusion set already mountedon the insertion needle 12. The time required for the placement of aninfusion set is reduced.

The injector device 10 includes a trigger-type actuator mechanism fortranscutaneous placement, with a controlled speed and force, of theinsertion needle 12 which is secured to the plunger 30, with theinsertion needle 12 oriented at an angular position relative to the skinof the patient in principally the manner as shown in internationalpatent application no. 99/33504 incorporated herein by reference.

The plunger 30 has a recessed head 32 (FIG. 3) at a lower or forward endthereof shaped for receiving the housing of the subcutaneous infusionset 14. Centrally in the recess, the head 32 is provided with the metalinsertion needle 12, which is securely connected thereto. The insertionneedle 12 may connected to the plunger in any suitable manner such as inthe process of molding the plunger 30, or the insertion needle 12 may bepress-fit in the plunger 30. The recess in the plunger head 32 need notprovide support for the infusion set 14 in the sense of providingresistance to removal of the infusion set 14. Such support may beprovided solely by the frictional engagement of the insertion needle 12with the cannula 26 or preferably with the sealing membrane within theinternal chamber of the infusion set 14. A rear end of the plunger 30has a trigger-type actuator assembly 34 cooperating with the rear end ofthe device housing 28, and includes a stem, which is longitudinallysplit to define a pair of trigger arms 38 which have out-turned triggerfingers 58 on the sides thereof. The trigger actuator assembly 34 isadapted to hold the plunger 30 in a retracted position, against theforce of a compressed helical drive spring 36. The trigger arms 38 ofthe actuator assembly 34 are adapted for fingertip depression to releasethe plunger 30 for spring-loaded travel toward the advanced position,and for corresponding transcutaneous placement of the insertion needle12, and of the cannula 26 travelling therewith, through the patient'sskin. In an alternative embodiment, release of the plunger 30 may becaused by pressing manually on diametrically opposed outside areas ofthe device housing 28 to deform the housing 28 and thereby effectrelease of the trigger arms 38.

FIGS. 1-5 illustrate construction details of the injector device housing28, wherein the lower or nose end thereof defines a flat and generallyplanar peripheral surface 25 for placement against the skin of a patientwith a longitudinal axis of the device housing 28 oriented generallyperpendicular to the patient's skin. A hollow bore of the device housing28 has a size and shape for reception of the infusion set 14, with theinsertion needle 12 extending through the cannula 26 and extendingtogether with the cannula 26 in a direction for placement on a patient.A releasable cover sheet 42 (FIGS. 1 and 2) is preferably secured to thedevice housing 28 at the nose end thereof to indicate the sterility ofthe infusion set 14. The device housing 28 may also include a narrowslot (not shown) extending parallel with the insertion needle 12 toaccommodate slide-fit reception of a coupling element projectinglaterally from the infusion set housing for coupling of the infusion setwith a pump (not shown), and longitudinally extending track slots 52(FIG. 3). The plunger 30 includes ribs 50 for guided reception withinthe track slots 52 formed in the device housing 28 to control themovement of the plunger 30 between the advanced position and theretracted position. The plunger 30 ribs 50 define a surface 51 near thehead 32 adapted to cooperate with a peripheral inner edge 29 at the noseend of the device housing 28 to limit movement of the plunger, therebydefining the advanced position of the plunger 30.

Thus, the forward or nose end of the device housing 28 accommodatesmovement of the subcutaneous infusion set 14 between the retractedposition disposed substantially at the rearward most end of the devicehousing 28, and the advanced position.

As will be understood, the trigger-type actuator assembly 34 generallyfunctions to releasably retain the plunger 30 in the retracted andcocked position, ready for rapid, and spring-loaded actuation upondepression of the trigger arms 38 to place the infusion set 14 on thepatient. More particularly, the trigger assembly 34 is initially lockedagainst a shoulder 66 formed on the device housing 28 by means of thetrigger fingers 58. The drive spring 36 comprises a coil springpositioned about the stem on the plunger 30 and reacts between arearward face 64 of the plunger head 32, and an internal shoulder 66′ onthe device housing 28. The drive spring 36 normally biases the plunger30 toward the advanced position. During manufacture of the injectordevice assembly, the infusion set 14 is seated in the recess formed inthe plunger head 32, either before or after the plunger 30 is moved tothe retracted position. In this retracted plunger position, the drivespring 36 is retained in a compressed and cocked condition, with thecannula 26 of the infusion set 14 being received on the insertion needle12. The releasable cover sheet 42 is then applied to the device housing28 at the nose end thereof.

In use of the injector device 10 with the infusion set 14, the coversheet 42 is first removed and the injector device 10 is placed firmlyagainst the patient's skin, with the infusion set 14 supported in theproper orientation and at a predetermined distance from the skin. A cap94, which prevents accidental projection of the infusion set 14 bypreventing access to the trigger arms 38, is removed. Simple depressionof the arms 38 releases the cocked plunger 30 for spring-loaded travelrapidly albeit with a controlled speed and force of insertion, to ensurepenetration of the patient's skin with minimal discomfort, and in amanner which properly places the insertion needle and cannula 26.

Following placement of the infusion set 14 the injector device withinsertion needle 12 is withdrawn quickly and easily from the cannula.Thereafter, the injector device can be discarded and the infusion set 14can be used in a normal mariner to deliver a selected medication throughthe infusion tubing and cannula 26 to the patient. As shown in FIG. 4,the safety cap 94 may conveniently be adapted to cooperate with anannular recess 33 formed in the head 32 of the plunger 30 for providingprotection against the needle 12.

It is noted that the removable cap 94, when sealed to the device housing28 at the end opposite the plunger head, together with the cover sheet42 enable the injector device 10 together with the infusion set 14mounted on the insertion needle 12 to be sterilised in a conventionalsterilisation process using e.g. ethylene oxide, where the sterilisingagent flows through the membrane formed by the cover sheet 42. By properchoice of the materials used for making the injector device, theinjector device may then remain sterile under normal conditions ofstorage, making any external packaging unnecessary.

An alternative embodiment of the invention is shown schematically inFIGS. 6-12, wherein components corresponding in function to thosedescribed previously with respect to FIGS. 1-5 are identified by commonreference numerals increased by 100. FIGS. 6-12 serve the purpose ofexplaining the principles involved in that embodiment, and the figuresshow schematic, partial cross-sectional views of the injector device.

FIGS. 6-12 show an injector device assembly including a modifiedinjector device 110 constructed from a reduced number of parts andhaving an alternative drive mechanism for advancing the plunger. Themodified injector device 110 comprises a generally cylindrical hollowdevice housing 128, a plunger 130 and a trigger-type actuator 134 formedintegrally with the plunger 130. A cover 194, preferably a flexiblemembrane, covers the top of the injector device 110 and a further cover142 covers the bottom end of the injector device 110.

The plunger 130 has a generally cylindrical form with a head 132 and acentral pin 129 including a metal insertion needle 112 secured theretoin a molding process, by press-fit, or by any other method providing asuitable resistance to loss of the insertion needle during use of thedevice. The pin 129 stops at a distance from a pair of outwardly turnedlegs 138′ at the head 132, to accommodate for the infusion set 114 inthe head 132 of the plunger 130. The insertion needle 112 extendsthrough the infusion set 114 in a similar manner as described withreference to FIGS. 1-6. An infusion set tubing 113 having a typicallength of between about 50 cm and 120 cm and connected to the infusionset 114 is wound up in the lower part of an annular space 115 betweenthe device housing 128 and the plunger 130 to form part of the assembly.

More specifically, the device housing 128 again has a forward or noseend defining a flat and generally planar surface 125 for firm placementagainst the skin of a patient. The plunger 130 additionally includes apair of resilient trigger arms 138 which are connected with the pair ofoutwardly turned legs 138′ and which have out-turned trigger fingers 158at the sides thereof. The trigger arms 138 are adapted and sized forpartial radial compression toward each other as they ride within thedevice housing when the plunger 130 is displaced from the advancedposition (FIG. 6) to the retracted position (FIG. 9). As the retractedposition is reached, the trigger arms 138 are spring-loaded by theresiliency to move first inwardly and then outwardly whereby the triggerfingers engage the upper surface of a shoulder 166 of the device housing128. In this position the trigger fingers 158 retain the plunger 130 inthe retracted position.

A drive spring 136 is mounted within the device housing 128 to drive theplunger towards the nose of the device housing in the retracted positionof the plunger 130, upon release of the trigger arms 138. The drivespring 136 is formed integrally with the device housing 128 and theplunger 130 in a molding process and may conveniently be formed of thesame plastics material as the plunger 130 and the device housing 128.The spring is shown in closer details in FIG. 12. The spring 136essentially comprises a number of elongated plastics strips 136, eachextending around a respective part of the periphery, of the plunger 130,in the annular space 115 between the plunger 130 and the device housing128. The drawing show an embodiment incorporating two such strips thateach extends around about one fourth of the periphery of the plunger130. Each strip 136 is integrally connected at one end 136″ with theplunger 130 and with the device housing 128 at the other end 136′. Inthe advanced position of the plunger shown in FIGS. 6-8 and 10-12, thestrips 136 are preferably essentially plane and non-deformed, However,when moving the plunger 130 to the retracted position shown in FIG. 9,the strips 136 of the spring are bend, setting up the required forcethat seeks to drive the plunger 130 towards the nose of the devicehousing 128. It is noted that this process normally gives rise to arotational movement of the plunger 130 about its central axis, which iscoincident with the insertion needle 112.

Operation of the injector device assembly shown in FIGS. 6-12 is asfollows. Since the injector device is preferably delivered to thepatient in an uncocked state to simplify the process of manufacture, theplunger 130 must first be moved to the retracted position. To allow forretraction of the plunger 130, the upper cover 194, which spans acrossthe device housing 128, and the lower cover 142 are first removed, asshown in FIG. 7. The lower cover 142 may be hingedly connected to thedevice housing 128. In this process, the infusion set 114 is exposedwith the pointed end 112A of the insertion needle 112 projecting fromthe end of the soft flexible cannula 126. The infusion set tubing 113 isthen connected to a suitable pump, and the infusion set 114 is primed(drop marked 300 in FIG. 8) by allowing medication to exit through thenarrow annular space between the cannula 126 and the insertion needle112 or, if a hollow needle is used, through the needle, as shown in FIG.18. The injector device 110 is then cocked by displacing the plunger 130with respect to the device housing 128 as illustrated by the arrow inFIG. 9, until the fingers 158 engage the upper shoulder 166 of thedevice housing 120, indicating that the injector device is now ready foruse. A release sheet 114′ is then removed exposing an adhesive materialon the bottom side of the infusion housing 114, and the patient or thenursing personnel then places the injector device on the patient's skin.The plunger 130 is released by application of an inwardly directedmanual force on the arms 138 to transcutaneously place the insertionneedle 112 and the cannula 126. In an alternative embodiment, release ofthe plunger 130 may be caused by pressing manually on diametricallyopposed outside areas of the device housing 128 to deform the housing128 and thereby effect release of the trigger arms 138.

The injector device 110 is then removed, leaving the infusion set 114 onthe patient's skin, illustrated by reference numeral 116, and the bottomcover 142 is then repositioned at the original place shown in FIG. 11for protection of the insertion needle 112 which projects partially fromthe nose end of the device housing 128.

The removable upper cover 194 and the bottom cover 142, when sealed tothe device housing 128, allow the injector device 110 together with theinfusion set 14 mounted on the insertion needle 112 to be sterilised ina conventional sterilisation process using e.g. ethylene oxide. For thispurpose one or both covers 142, 194 may comprise a permeable membraneallowing through-flow of the sterilising agent. By choosing suitablematerials, the injector device may then remain sterile for a long timeunder normal conditions of storage whereby no further packaging isrequired to ensure sterility of the assembly at the time of use. Forthis purpose, at least one of the covers, preferably the upper cover194, may carry printed indicia relating to the shelf life of theassembly. One suitable material for the permeable membrane is Tyvec™.

FIGS. 13-16 show a third embodiment of the invention wherein componentscorresponding in function to those described previously with respect toFIGS. 1-5 are identified by common reference numerals increased by 200.FIGS. 13-16 serve the purpose of explaining the principles involved inthat embodiment, and the figures show schematic, partial cross-sectionalviews of an injector device 210. The injector device 210 is particularlysuitable for the placement of a subcutaneous infusion set 214 at anacute angle relative to the skin of a patient.

As best seen in FIG. 13, which shows the injector device in a semi-openstate, the injector device 210 has a device housing 228 with a flattenedbox-like structure with parallel major walls 224, 219, the wall 219including a frangible area 219′″, see FIG. 16, allowing the wall 219 tobe split by manually pulling flap 229 (FIG. 13), thereby forming twoseparate wall parts 219′, 219″ for a purpose that will be explainedlater. The housing 228 also includes a front wall 227 at the nose end ofthe injector device, and a rear wall 280, and opposed parallel sidewalls 225 frangibly connected to wall part 219′. The injector device 210is presented to the consumer as a closed, box-shaped item, which mayeasily be provided with printed text as required.

FIG. 14 shows the injector device in the same state shown in FIG. 13;however, a part of the walls 224, 227 and 219, as well as wall 225 havebeen omitted to show the interior of the injector device 210.

The injector device 210 comprises a plunger 230 mounted for longitudinalsliding movement within the box-shaped housing between a rearwardretracted position (FIG. 14) and a forward advanced position (FIG. 15).The device housing 228 and the plunger 230 are preferably formed of aplastics material. The device housing 228 may alternatively bemanufactured from a blank of rigid cardboard. The plunger 230 has arecessed head 232 (best seen in FIG. 16) at a forward end thereof shapedfor receiving the housing of a subcutaneous infusion set 214. Centrallyin the recess, the head 232 is provided with a projecting metalinsertion needle 212 securely connected thereto. The plunger 230 neednot provide support for the infusion set as understood in the sense ofproviding resistance to removal of the infusion set. Such support maypreferably be provided by the frictional engagement of the insertionneedle 212 with the infusion set 214. A drive spring 236 positionedbehind wall 280 reacts between a rearward faces 264 of the plunger head232. The drive spring 236 normally biases the plunger 230 toward theadvanced position. The front end of the plunger 230 has a trigger button258 cooperating with the wall 224 of the device housing 28. In theretracted state of the plunger shown in FIG. 14, the trigger button 258extends through an opening 222 formed in the upper wall 224 of thedevice housing 228 and aligned for reception of a release tab 220 on thewall 219′, as will be explained.

The trigger button 258 may be adapted for fingertip depression torelease the plunger 230 for spring-loaded travel toward the advancedposition, and for corresponding transcutaneous placement of theinsertion needle 212, and of the cannula 226 travelling therewith,through the patient's skin. Preferably, the button 258 is depressed bypivoting wall part 219′ about line 227′. When the tab 220 formed on theexternal surface of wall part 219′ is aligned with the slot 220, thetrigger button 258 can be depressed to actuate the spring-lockedplunger, by manually pressing down wall part 219′.

Before opening the device housing 210, that is, before separating wall219, 219′ along frangible line 219′″, the assembly is maintained understerile conditions. A removable cover sheet 294 (FIG. 13) is sealed towall 224 to cover opening 222. All other walls defining the closedhousing 210 being sealed together, the cover sheet 294, when beingpermeable allows the injector device 210 together with the infusion set214 mounted on the insertion needle 212 to be sterilised in aconventional sterilisation process using e.g. ethylene oxide, where thesterilising agent flows through the permeable membrane.

FIG. 17 shows an example of an infusion set 14 suitable for use with theinjector device according to the invention. The infusion set 14 includesa housing 3 with an internal chamber (not shown). The internal chamberreceives medication via infusion tubing 113 which may be detachablyconnected to the housing 3 by any suitable connector 7. The base 24 ofthe housing 3 may be a flexible sheet of a woven material secured to thehousing 3 such as by means of an adhesive and carrying an adhesivecovered by a release sheet 14′ which is removed to expose the adhesiveprior to placement of the infusion set. The infusion set 14 has aprotruding soft and flexible cannula 26, which communicates with theinternal chamber. An internal passage which is sealed by a sealingmembrane 4 and which is penetrated by the insertion needle of theinjector device extends through the housing opposite the cannula 26.

FIG. 18 shows how priming of the infusion set may be carried out priorto the placement of the infusion set using an injector device with aplunger shown only in part and carrying a hollow insertion needle 12,112 having a lateral opening 12B, 112B. The medical insertion needle 12,112 of the injector device extends into the internal chamber 2 of theinfusion set 14 and through the cannula 26, 126, when the infusion set14 is mounted in position on the injector device. Medication 6 is thensupplied through tubing 113, into the internal chamber 2. To allow theuser to visibly confirm that the internal chamber 2 has been completelyfilled with medication, the lateral opening 12B, 112B allows themedication to flow into the interior of the needle 12, 112 and to exitthrough pointed end 12A, 112A.

FIG. 19 shows in an exploded view a presently preferred embodiment ofthe injector device assembly. In respect to FIGS. 6-12, elements havinga similar function are identified by the same numerals increased by 200.

The injector device 310 includes respective removable covers 342, 394,the cover 342 having a hollow for accommodating a part of the insertionneedle 312 when the cover 342 is secured to the housing 328, such as bysnap engagement with the rim 309 of the housing 328. The cover 342, thehousing 328, the plunger 330 and a drive with a spring for advancing theplunger 330 to the advanced position are preferably made of plasticswhile the cover 394 may be a flexible foil secured to the housing 328 byan adhesive. Preferably, the covers 342, 394 serve as bacterialbarriers, the flexible foil 394 being of medical paper. An insertionneedle 312 is preferably secured in a stable manner to the plunger 330of the injection device, such as by press-fitting, the plunger 330having a narrow central passage wherein an end of the insertion needle112 is lodged. As will appear, the plunger 330 and the drive mayconveniently be formed integrally as a single component in a mouldingprocess.

The ring-shaped housing 328 is flexible in the sense that theapplication of a manual force against diametrically opposed depressions303 of fingertip size will give rise to a slight deformation of thehousing 328 such that it assumes a slightly oval shape when viewed fromabove for bringing about a release of the plunger in the retractedposition and cause a spring-loaded movement of the plunger 330 towardsthe advanced position, as will be explained. For maintaining the plunger330 in the retracted position the housing 328 is provided with twoopposed ledges 366. Moreover, the housing 328 is provided with opposeddovetail projections 301 extending along the same general direction asthe insertion needle 312 and adapted to connect with complementaryrecesses in the aforementioned spring, to secure the spring in relationto the housing 328.

The plunger 330 generally includes a head 332, a hub 331 and, oppositethe head 332, an enlarged gripping portion 331′ which allows a user tomanually pull the plunger 330 to a retracted position. The head 332preferably carries a marking M representing the place where the 113tubing exits the infusion set 314 located there under whereby the usercan check the orientation of the tubing after placement of the infusionset. The head 332 moreover has a recess 332′ for accommodating theinfusion set 326 with cannula 326 through which the insertion needle 312extends, the infusion set 314 preferably being maintained in position byfrictional engagement of the insertion needle 312 with an inside surfaceof the infusion set 314. The plunger 330 has two opposed rigid walls 306extending radially outwardly from the hub 331. The walls 306 extend inthe axial direction of the device 310, i.e. in the same generaldirection as the insertion needle 312, and are connected to theaforementioned spring. Moreover, as best seen in FIG. 20 d, the walls306 each carry a lateral projection 307 with a finger 358 which isreleasably locked in engagement with a corresponding one of the ledges366 of the housing 328 by snap action in the retracted position of theplunger 330. The depressions 303 preferably being offset with respect tothe ledges 366 by about 90° will cause the opposed ledges 366 to moveapart when the aforementioned manual force is applied and the housing328 assumes an oval shape, thereby bringing the finger 358 on each wall306 out of engagement with the corresponding ledge 366. For retaining aproximal part nearmost the infusion set of a tubing 113 (not shown)wound around the plunger 330 in the same general manner shown in FIG. 6,wall 306 has a groove G best seen in FIGS. 21 c and d sized to receive asmall length of the tubing and to prevent the infusion set 314 frombeing inadvertently pulled away from the plunger 330 by the user whenthe tubing is unwound for connection with a medical fluid supply.

The drive which acts to drive the plunger 330 from the retractedposition towards the advanced position when the fingers 358 aredisengaged comprises a spring including four thin and flexible plasticsstrips, of which two opposed strips 336A extend about halfway around theplunger 330 at the level of the gripping portion 331′ while two otheropposed strips 336B extend about halfway around the plunger 330 at thelevel of the head 332, as viewed in the advanced and unbiased positionof the plunger shown in FIGS. 19 and 20 a-e. One end 336′ of one of thestrips 336A and one end 336′ of one of the strips 336B is rigidlyconnected to one of the walls 306, while one end 336′ of the other oneof the strips 336A and one end 336′ of the other one of the strips 336Bis rigidly connected to the other one of the walls 306. Preferably, thestrips 336A and 336B are integrally connected with the walls 306 in amoulding process where the plunger 330 and the spring formed from thestrips 336A and 336B is formed in one moulding operation.

The spring also comprises two rigid opposed rigid walls 302 that extendin the axial direction of the device 310 and that are each rigidlyconnected with the second end 336″ of one of the strips 336A and thesecond end 336″ of one of the other strips 336B. The rigid walls 302 arepreferably integrally connected with the strips 336A and 336B at thesecond end thereof. The walls rigid 302 each have an axially extendingrecess 305 which is complementary with the dovetail projection 301 onthe housing 328. When the plunger 330 with the spring is mounted withinthe housing 328 the dovetail projection 301 is slid into the recess 305by axial movement; by selecting proper dimensions of the dovetailprojection 301, and possibly also by performing this operation at apredetermined temperature, a press-fit may result that preventssubsequent removal of the plunger 330. Alternatively, or additionally,the plunger 330 may be secured using glue, or using a welding process.The two rigid walls 302 of the spring also comprise a respectiveprojection 308 with a lower surface which in the advanced position ofthe plunger 330 is essentially coplanar with the rim 309 of the housing328. The projections 308 include a clip-like retainer C for securing adistal part of the tubing wound around the plunger 330, therebymaintaining the tubing in position until unwound by the user.

As will be understood, the walls 302 are fixed in relation to thehousing 328, and the strips 336A and 336B, being thin and flexible,define the parts of the spring that undergo a change in shape uponretraction of the plunger 330 and that through this change of shapegenerate the force acting on the plunger 330 via the connections at theends 336′ and required to advance the plunger 330 to the advancedposition upon disengagement of the fingers 358. The shape of the strips336A and 336B in the deformed condition when the plunger 330 is held inthe retracted position is shown in FIGS. 21 a-d. The connection betweenthe strips 336A, 336B and the walls 302, 306 being rigid, in the sensethat bending moments arising in the strips 336A, 336B upon retraction ofthe plunger 330 are transferred to the walls 302, 306, brings about adeformation of the strips 336A, 336B as shown.

It will be understood that the resiliency of the spring is generallydefined by the elastic properties of the flexible strips 336A, 336Bwhich should be selected such that the drive is capable of advancing theplunger 330 to the advanced position at least once, followingretraction. The spring would normally allow the piston to be retractedseveral times, and provide the required force for subsequently advancingthe plunger 330. However, the device being normally a disposable unitrequires the spring to be formed with the capability to only a limitednumber of times advance the plunger 330 at one given speed, and thespring need not be capable of returning the plunger to the exactoriginal position after several times of use.

As seen best in FIG. 19, the two strips 336B each carry a wall member304 which provides support for a tubing (not shown) connected to theinfusion set 314 and wound around the plunger 330 in the annular space315 between the plunger 330 and the housing 328.

FIGS. 22 a and 22 b show an injector device without an insertion needlesecured to the plunger.

FIGS. 23 a and 23 b show a schematic cross-sectional view through theinfusion set 14 of FIG. 17. This preferred infusion set is equallysuited for use with or without the injector device described herein. Asshown in FIG. 23 a, the plastics infusion set housing 3 has an internalchamber including a narrow cylindrical portion 2 and an enlargedcylindrical portion 2′, in an upper part of which is fixed a sealingmembrane 4 which may be penetrated by a retractable insertion needle 12with a pointed end 12A, shown in FIG. 23 b, for placing the infusion set14 on a patient by means of a flexible cannula 26. The cannula 26 has asmall diameter tubular portion 26″ and a larger diameter tubular portion26′ which is press-fit or otherwise secured inside the narrowcylindrical portion 2 of the housing 3 chamber. A plug-like hollowtubular member 1 has a head portion nested in the enlarged cylindricalportion 2′, and a portion 1″ of smaller external diameter which extendsinto the larger diameter tubular portion 26′ of the cannula, preferablyapplying a radial pressure against the inside surface of the cannula 26to thereby secure the cannula in place within the narrow cylindricalportion 2 of the housing 3 chamber. For this purpose, the plug-likehollow tubular member 1 preferably exhibits some resiliency.

The head portion of member 1 has an upper surface bearing tightlyagainst the sealing membrane 4, and has a diameter selected such that anannular passage 2″ is defined between the head portion and the housing 3wall defining the enlarged cylindrical portion 2′ of the internalchamber. This annular passage is in communication with infusion tubing113 supplying fluid to the infusion set 14. The head portion of member 1moreover has a number of radially directed entry ports 1′ of which oneis shown in FIG. 23 a, thereby allowing fluid to flow from the passage2″ into the interior of member 1 and further on into the small diametertubular portion 26″ of the cannula 26″, and into the patient when theinfusion set has been secured in place by an adhesive on base 24. Thebase 24 of the housing 3 may be a flexible sheet of a woven materialsecured to the housing 3 such as by means of an adhesive and carrying anadhesive covered by a release sheet 14′ which is removed to expose theadhesive prior to placement of the infusion set.

FIG. 23 b shows how the infusion set may be primed prior to placement,when a hollow insertion needle 12, which may be secured to a plunger ofthe injector device described herein, extends through the cannula 26.The hollow insertion needle 12 has a lateral opening 12B that defines anentry port whereby fluid entering the interior of member 1 through theentry ports 1′ may flow into the interior of the hollow insertion needle12 and out of the insertion needle 12 at pointed end 12A. Forestablishing communication, the inside diameter of the portion 1″ ofmember 1 may as shown be slightly greater than the outside diameter ofthe insertion needle 12 such that an annular passage 5 is formedallowing fluid to flow from tubing 113 into the insertion needle 12.

A variety of further modifications and improvements to the automaticinjector device unit of the present invention will be apparent topersons skilled in the art. Accordingly, no limitation oh the inventionis intended by way of the foregoing description and accompanyingdrawings, except as set forth in the appended claims. It is noted thatthe assembly may, depending on the design, be put on the market as such,i.e. with no further packaging being required. Moreover, the injectordevice, provided with an insertion needle or not, is not exclusivelysuited for placing an infusion set but may also be used for placing atranscutaneous glucose sensor. FIG. 24 shows the injector device of FIG.19 with the opposed sealed covers and with a glucose sensor housing Gincluding a sensor needle N inserted into the patient by an insertionneedle which is arranged in the plunger head recess 332′ in lieu of aninfusion set. The glucose sensor G may have a connecting cable L woundaround the plunger 330 in the same manner as the infusion set tubingdescribed above, or may have ports for connecting the glucose sensor toan external device for recording the glucose level of the patient.

1. An injector device for transcutaneously placing at least a portion ofa cannula of a medical device through the skin of a patient, saidinjector device comprising: a device housing; a carrier memberreleasably carrying said medical device, said carrier member adapted formovement relative to said housing for advancement of said medical devicetowards the skin of a patient, said carrier member including a piercingmember and a recess formed at a forward end of said carrier member, saidrecess contoured to receive a portion of said medical device; a driveoperably connected to said carrier member, said drive being adapted forurging movement of said carrier member; and a cover removably connectedto a portion of said device housing, said cover receiving at least aportion of said piercing member therein; wherein said piercing member isadapted to receive said cannula of said medical device.
 2. The injectordevice of claim 1 wherein said housing includes a forward end defining agenerally planar surface for placement against the skin of a patient. 3.The injector device of claim 1 wherein said medical device is asubcutaneous infusion set.
 4. The injector device of claim 1 whereinsaid medical device is a sensor.
 5. The injector device of claim 1wherein said piercing member extends from said carrier member.
 6. Theinjector device of claim 1 wherein said drive urges sliding movement ofsaid carrier member from a retracted position to an advanced position.7. The injector device of claim 1 wherein said piercing member comprisesa needle.
 8. The injector device of claim 1 further comprising aretaining member for releasably retaining said carrier member in aselected position relative to said housing.
 9. The injector device ofclaim 8 wherein said housing is deformable to release said retainingmember.
 10. The injector device of claim 9 wherein said housing ismanually deformable to release said retaining member.
 11. The injectordevice of claim 1 wherein said drive comprises a spring.
 12. Theinjector device of claim 1 wherein said drive comprises at least oneflexible plastic strip extending around a portion of a periphery of saidcarrier member, said at least one strip extending in a space betweensaid carrier member and said housing.
 13. The injector device of claim 1wherein said cannula is soft and flexible.
 14. The injector device ofclaim 1 wherein said device is generally cylindrically shaped.
 15. Theinjector device of claim 1, wherein said piercing member issubstantially non-detachably secured to said carrier member.
 16. Aninjector device for transcutaneously placing at least a portion of acannula of a medical device through the skin of a patient, said injectordevice comprising: a generally cylindrically shaped housing having acavity formed therein, said housing including a forward end, the forwardend defining a generally planar surface for placement against the skinof the patient; a carrier member adapted for at least partial receptionin said cavity and releasably carrying said medical device, said carriermember comprising at least one piercing member secured to said carriermember; a drive for urging movement of said carrier member relative tosaid housing; and a substantially rigid cover releasably connected overa cylindrical perimeter of said housing, said cover covering said cavityand said piercing member; wherein said drive extends at least partiallyaround at least a portion of said carrier member, and wherein said atleast one piercing member is adapted to receive at least a portion ofsaid cannula of said medical device.
 17. The injector device of claim 16wherein said drive comprises a spring.
 18. The injector device of claim16 wherein said drive comprises at least one flexible plastic stripextending around a portion of a periphery of said carrier member, saidat least one strip extending in a space between said carrier member andsaid housing.
 19. The injector device of claim 16 wherein said driveurges said carrier member from a retracted position to an advancedposition relative to said housing for placement of said medical device.20. The injector device of claim 16 further comprising a retainingmember for releasably retaining said carrier member in a selectedposition relative to said housing.
 21. The injector device of claim 20wherein in said retaining member retains said carrier member in aretracted position in said housing prior to transcutaneous placement ofsaid medical device.
 22. The injector device of claim 20 wherein saidhousing is deformable to release said retaining member.
 23. The injectordevice of claim 22 wherein said housing is manually deformable torelease said retaining member.
 24. The injector device of claim 16further comprising a recess formed at a forward end of said carriermember, said recess contoured to receive a portion of said medicaldevice.
 25. The injector device of claim 16 wherein said medical deviceis placed to the skin of the patient by positioning a forward end ofsaid injector device on the skin and advancing said carrier memberrelative to said skin.
 26. The injector device of claim 16, wherein saidpiercing member is substantially non-detachably secured to said carriermember.
 27. An injector device for transcutaneously placing at least aportion of a cannula of a medical device through the skin of a patient,said injector device comprising: an insertion member substantiallynon-detachably secured to a carrier member releasably carrying saidmedical device, said insertion member being adapted for insertion withinsaid cannula; a cylindrical body for reception of said carrier memberwithin said cylindrical body, said cylindrical body having a forwardend, said forward end defining a generally planar surface for placementagainst the skin of the patient; and a removable cover secured to an endportion of said cylindrical body for accommodating a part of saidinsertion member; wherein said carrier member is advanced relative tosaid skin for placement of said medical device when said forward end isplaced against the skin of a patient.
 28. The injector device of claim27 further comprising a drive for biasing said carrier member relativeto said cylindrical body.
 29. The injector device of claim 27 furthercomprising a retaining member for releasably retaining said carriermember in a position relative to said cylindrical body.
 30. The injectordevice of claim 29 wherein said retaining member releasably retains saidcarrier member in a retracted position relative to said cylindricalbody.
 31. The injector device of claim 29 wherein said body isdeformable to release said retaining member.
 32. The injector device ofclaim 31 wherein said body is manually deformable to release saidretaining member.
 33. The injector device of claim 27 wherein saidinsertion member is substantially non-detachably secured to said carriermember by press-fit.
 34. The injector device of claim 27 furthercomprising a recess formed at a forward end of said carrier member, saidrecess contoured to receive portion of said medical device.
 35. A methodof inserting at least a portion of a medical device through the skin ofa patient, said method comprising: providing a sterile medical devicecontained within an insertion device, the insertion device having acover removably connected to a portion of the insertion device to ensuresterility of the medical device, the insertion device having a carrierbody mounted for movement relative to the insertion device and themedical device mounted on an insertion member on said carrier body andat least partially in a contoured recess formed in said carrier body;removing the cover from the insertion device to expose the medicaldevice mounted on the insertion member; advancing said insertion membertoward the skin of the patient to insert at least a portion of saidinsertion member and at least a portion of said medical device thoughthe skin for placement of the medical device; removing said insertionmember and said carrier from said medical device while maintaining theplacement of said medical device relative to the patient.
 36. The methodof claim 35 further comprising providing a drive for advancing saidinsertion member toward the skin of the patient.
 37. The method of claim35 wherein said body is cylindrical.
 38. The method of claim 35 furthercomprising providing a retaining member for releasably retaining saidcarrier body in a selected position prior to advancing said insertionmember towards the skin.
 39. The method of claim 38 wherein saidinsertion device is deformable to release said retaining member.
 40. Themethod of claim 39 wherein said insertion device is manually deformableto release said retaining member.
 41. The method of claim 35, comprisingproviding a substantially non-detachably secured insertion member onsaid carrier body.
 42. An injector device assembly including asubcutaneous infusion set, said subcutaneous infusion set including acannula for the delivery of medication, said assembly comprising: aninjector device, said injector device comprising a plunger; a devicehousing, said plunger being received within said device housing formovement relative to the housing, for transcutaneous placement of saidinsertion needle upon movement of the plunger with said needle relativeto the housing, said cannula being oriented for transcutaneous placementupon movement of the plunger with said needle; a spring for urging saidplunger relative to the housing; and a medical insertion needle mountedon said plunger for transcutaneous placement of said cannula of saidsubcutaneous infusion set, said insertion needle extending through atleast a portion of said cannula; and a releasable cover secured to anend portion of said injector device for ensuring sterility of saidinfusion set prior to use and for accommodating a part of said medicalinsertion needle; wherein said plunger and said insertion needle areremovable from said subcutaneous infusion set while maintaining thetranscutaneous placement of the cannula.
 43. The injector deviceassembly according to claim 42 wherein said subcutaneous infusion setincludes an adhesive for engaging the skin of said patient, saidinjector device with said plunger with said insertion needle beingremovable from said subcutaneous infusion set upon said adhesiveengaging said patient.
 44. The injector device assembly according toclaim 42 wherein indicia relating to the shelf life of the assembly areprinted on said cover.
 45. The injector device assembly according toclaim 42, said injector device assembly being provided as a sterilesealed, single use assembly.
 46. The injector device assembly accordingto claim 42, said insertion needle being substantially non-detachablysecured to said plunger.
 47. The injector device assembly according toclaim 42, wherein the spring urges said plunger from the retractedposition toward the advanced position.
 48. The injector device assemblyaccording to claim 47, wherein said device housing has a forward enddefining a generally planar surface for placement against the skin of apatient with the device housing in a predetermined orientation relativeto the patient's skin.
 49. The injector device assembly according toclaim 47, wherein a forward end of said insertion needle opposite saidplunger is substantially retracted within the device housing when theplunger is in the retracted position.
 50. The injector device assemblyaccording to claim 47, wherein the infusion set comprises a tubing, saiddevice housing including a space for accommodating said tubing.
 51. Theinjector device assembly according to claim 47, further including atrigger for releasing said plunger for movement of said plunger by saidspring.
 52. The injector device assembly according to claim 51, whereinthe trigger includes a trigger actuator for fingertip depression. 53.The injector device assembly according to claim 51, wherein the triggerincludes a lock for releasably locking the plunger in the retractedposition.
 54. The injector device assembly according to claim 42,wherein the insertion needle is substantially incapable of delivering afluid.
 55. The injector device assembly according to claim 42, whereinsaid insertion needle is hollow and has a lateral opening near saidplunger.
 56. The injector device assembly of according to claim 42, saidcannula being soft and flexible.
 57. An injector device assemblyincluding a subcutaneous infusion set, said subcutaneous infusion setincluding a cannula for the delivery of medication, said assemblycomprising: an injector device, said injector device comprising a devicehousing; a plunger being received within said device housing formovement between an advanced position and a retracted position; amedical insertion needle mounted on said plunger for transcutaneousplacement of said cannula of said subcutaneous infusion set uponmovement of the plunger with said needle from said retracted position tosaid advanced position, said insertion needle extending through at leasta portion of said cannula, said cannula being oriented fortranscutaneous placement upon movement of said plunger with said needlefrom said retracted position to said advanced position; a spring forurging said plunger from the retracted position toward the advancedposition; and a releasable cover secured to said injector device forensuring sterility of said infusion set prior to use; wherein saidplunger and said insertion needle are removable from said subcutaneousinfusion set while maintaining the transcutaneous placement of thecannula, wherein said spring comprises a number of individual, elongatedflexible plastics strips extending around a respective part of theperiphery of the plunger, in an annular space between the plunger andthe device housing, each strip being connected with the plunger and withthe device housing.
 58. The injector device assembly of claim 57,wherein said strips are integrally molded with said plunger and saiddevice housing.
 59. The injector device assembly of claim 57, whereineach strip is connected at one end with the plunger and with the devicehousing at the other end, each strip being essentially planar andnon-deformed in the advanced position of the plunger.
 60. The injectordevice assembly of claim 49, said housing having a flat, box shapedconfiguration.
 61. A method of making an injector device assembly, saidmethod comprising: providing a subcutaneous infusion set having acannula for the delivery of medication; providing an injector device,said injector device having a plunger with a medical insertion needlemounted thereon; mounting said cannula of said infusion set on saidplunger with said insertion needle protruding from an end of saidcannula; applying a cover over an end of said injector device andremovably securing said cover to a portion of said injector device toenclose a cavity within said injector device; and sterilizing saidinjector device assembly.
 62. The method according to the claim 61,wherein said cover comprises a membrane cover sheet.
 63. The methodaccording to claim 61, further comprising providing a second releasablecover.
 64. The injector device of claim 15 wherein said piercing memberis substantially non-detachably secured to said carrier member bypress-fit.